Access Enhanced SARS-CoV-2 Research Results with Creative Biolabs' Neutralizing Antibodies

Empowered by the high-end technology platform for antibody production and extensive experience in antibody development and engineering, Creative Biolabs can provide first-level neutralizing antibody (NAb) products, analytical services, and technical support.


The COVID-19 pandemic stimulates the tide of developing effective vaccines and drugs throughout the world. Recent studies have revealed that neutralizing antibodies obtained from patients with COVID-19 can bind to the SARS-CoV-2, block the receptor binding activity, and therefore suppress the virus. Creative Biolabs provides a bank of  HYPERLINK "" neutralizing antibodies for research on SARS-CoV-2 to assist with corresponding projects from global customers, which include but are not limited to:


* Anti-SARS-CoV-2 RBD Recombinant Antibody

* Anti-SARS-CoV-2 N Recombinant Antibody

* Anti-SARS-CoV-2 S Recombinant Antibody

* Anti-SARS-CoV-2 S1 Recombinant Antibody


Those antibodies target proteins that are essential for the viral infection process, such as N (required for coronavirus RNA synthesis), S, S1, RBD of SARS-CoV-2 (essential in the binding of the virus to the host cell during infection).


All of the neutralizing antibodies available at Creative Biolabs are generally classified into 3 groups, i.e. primary antibody, secondary antibody, and isotype control, which could meet with almost every research purpose.


The primary antibodies are applicable for a wide range of research subjects, including but not limited to cellular marker, stem cell, cancer research, and infectious disease, which can specifically bind to the antigens of interest, and be used for laboratory tests of immunology to locate cellular markers, identify stem cell characteristic, detect viral infections, and so on.


Secondary antibodies mainly function as signal detection and amplification, which are usually labeled with fluorescent dyes or enzymes for biochemical assays like enzyme-linked immunosorbent assay (ELISA), flow cytometry (FC), immunofluorescence (IF), western blot (WB), etc.


Isotype control, as an antibody lacking in specificity to the target, is used as a negative control for differentiating non-specific background signals induced by off-target binding. Creative Biolabs offers:


* Human IgG1 Isotype Control

* Human IgG2 Isotype Control

* Human IgG4 Isotype Control

* Mouse IgG2a Isotype Control

* Mouse IgG2b Isotype Control

* Rat IgG2a Isotype Control

* Rat IgG2b Isotype Control

* Rabbit IgG Isotype Control



In addition to the above-mentioned antibodies for various research targets like SARS-CoV-2, clients with specific requirements can also find corresponding solutions at Creative Biolabs whose scientists can not only handle developing and engineering antibodies with the high-end recombinant antibody production platform but also are capable of offering analysis services.


Company Profile

Creative Biolabs was established by a group of Ph.D. level scientists specialized in antibody design and engineering in New York. For over a decade of exploration in the field of neutralizing antibody, experts at Creative Biolabs can help develop high-quality neutralizing antibodies and offer first-level analysis services to global customers. Up to now, thousands of  neutralizing antibodies have been isolated and expressed successfully, which facilitate the research of developing new vaccines targeting viral infection, and are applied as novel biological therapeutics.

Back to news